A Study to Evaluate the Safety, Reactogenicity, and Immune Response of the GSK Vaccines Institute for Global Health (GVGH) Quadrivalent Pan-Salmonella Vaccine With and Without Alum in Healthy Young Adults

NCT07663032 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

196

Enrollment

INDUSTRY

Sponsor class

Conditions

Salmonella Infections

Interventions

BIOLOGICAL: Pan-Salmonella-with-Alum (Low dose) vaccine
BIOLOGICAL: Pan-Salmonella-with-Alum (Full dose) vaccine
BIOLOGICAL: Pan-Salmonella-without-Alum (Low dose) vaccine
BIOLOGICAL: Pan-Salmonella-without-Alum (Full dose) vaccine
BIOLOGICAL: Typhoid Vi conjugate vaccine
OTHER: Placebo

Sponsor

GlaxoSmithKline